Safety and Immunogenicity of a Single Dose of MenACYW Conjugate Vaccine at Least 3 Years Following Initial Vaccination With Either Menomune Vaccine or MenACYW Conjugate Vaccine in Older Adults
Latest Information Update: 21 Dec 2023
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
- Focus Pharmacodynamics; Registrational
- Sponsors Sanofi Pasteur
Most Recent Events
- 09 Jun 2022 Status changed from active, no longer recruiting to completed.
- 25 Apr 2022 Planned End Date changed from 1 Apr 2022 to 1 May 2022.
- 16 Nov 2020 Planned End Date changed from 15 Apr 2022 to 1 Apr 2022.